A recent study indicates that patients who come off popular GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who halt conventional lifestyle plans.
Research printed in a prominent health publication shows that while obese individuals can lose substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"People buying these drugs need to be aware of the risk of quick weight regain when the therapy concludes," warns expert Dr. Susan Jebb.
This pace of regain implies a return to original mass in about a year and a half.
Weighing Treatments
The study, which examined 37 of studies involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with other pills.
Researchers emphasize that individuals who shed pounds through dieting usually see a less rapid creep back—around 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Doctors propose the way of the jabs accounts for the heightened weight return.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate appetite.
"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' results in appetite is unsuppressed, making excessive eating a significant risk."
An Ongoing Issue?
The NHS recommend the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Professionals say that, considering the high risk of weight regain, the therapy might need to be ongoing.
This opinion is reinforced by drug manufacturers, who say that the findings "highlight the persistent character of excess weight," comparing it to managing diseases like diabetes.
User Accounts
Individuals who have discontinued the medication explain a intense resurgence of appetite.
"It felt as if something that goes on and you're instantly extremely hungry," described an individual.
The struggle is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.
Widespread Interest
Recent estimates indicate that a significant number of adults in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is more common among women compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Finally, researchers emphasize that while these medications are potent tools for shedding pounds, they are not a permanent cure and maintained weight loss hinges on integrated lifestyle management.
